1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

FEROKA Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2014

Location

Seoul South Korea

Primary Industry

Medical Devices & Equipment

About

Based in South Korea, and founded in 2014, FEROKA Inc., formerly known as LOCOOP, operates as a drug delivery company. The company was founded by COO Induk Lee and Yeo Myung Lim. In August 2022, FEROKA raised KRW 10 billion in Series B funding from JETEMA, WELCOME CAPITAL, IBK Capital, and HB Investment. The funding gives FEROKA a pre-money valuation of KRW 50 billion. As of 2022, the company’s CEO is H.S. Kim. FEROKA offers microneedle technology, which is a drug delivery system (DDS) that is used by medical professionals for injections and tests. The microneedle consists of a multi-layer structure that has a shaft and a drug layer. With the help of its two-layer structure, medicines can be delivered directly to the patient’s skin layer. In addition, the company’s portfolio offers a product called the Delta Robot 3D Printer. The company uses its needle technology for various treatments, including epidermolysis bullosa (EB) treatment, obesity treatment, and lung cancer treatment. The company plans to use the funds raised in August 2022 for research and development to graft microneedles into vaccines and gene therapy products.
Current Investors
HB Investment, IBK Capital, Welcome Capital

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Surgical Devices, Medical Equipment Distributors
Website
www.feroka.net
Verticals
3D Printing, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2018
11,441,000
-
(54,717,000)
(478.3%)
-
-
(55,188,000)
(482.4%)
31 Dec 2019
167,979,000
1368.2%
(7,161,000)
(4.3%)
-
-
583,000
0.3%
31 Dec 2020
31 Dec 2021
31 Dec 2022

Unlock the recent years of financials and more for FEROKA Inc..

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.